Compare MMS & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MMS | STVN |
|---|---|---|
| Founded | 1975 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Business Services | Containers/Packaging |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.7B |
| IPO Year | 1997 | 2021 |
| Metric | MMS | STVN |
|---|---|---|
| Price | $64.94 | $16.29 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $25.67 |
| AVG Volume (30 Days) | ★ 586.7K | 575.1K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.02% | 0.39% |
| EPS Growth | ★ 10.42 | N/A |
| EPS | ★ 1.70 | N/A |
| Revenue | ★ $2,392,236,000.00 | N/A |
| Revenue This Year | $0.44 | $9.67 |
| Revenue Next Year | $5.15 | $9.99 |
| P/E Ratio | $38.37 | ★ $27.15 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $60.75 | $12.89 |
| 52 Week High | $100.00 | $28.00 |
| Indicator | MMS | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 38.43 | 65.08 |
| Support Level | $60.75 | $13.58 |
| Resistance Level | $70.82 | $16.69 |
| Average True Range (ATR) | 1.92 | 0.76 |
| MACD | 0.09 | 0.23 |
| Stochastic Oscillator | 15.89 | 74.29 |
Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.